The VIVISOL Group belongs to the SOL Group which, since it was founded in 1927, has developed its business in production, applied research and commercialisation of technical, pure and medicinal gases. The SOL Group added the home care assistance activity to its core business in 1986. At present, SOL has an extensive presence in the Central European markets and also in southeast Europe, with produc
tion facilities and commercial activities in 21 European countries and in India. The founding partners of the Group are the Annoni and Fumagalli families, who remain as owners of the company today. In addition, members of both families are actively involved in managing the group. VIVISOL was founded in 1986 and now has subsidiaries throughout the European Union, namely in Austria, Belgium, France, Deutschland, Greece, Italy, Netherlands, Slovenia, Spain, and the UK. The company has over 40 territorial centres, through seven direct foreign branches and four fully controlled affiliates with independent brands, providing home and hospital assistance services to over 285,000 patients each day. VIVISOL constantly focuses on developing, evolving and refining our solutions through evaluation, assessment and comparison of the different options available in the healthcare sector. We aim to provide patients with the best service possible in alignment with the needs and ongoing development of the company. The Group also constantly researches the many new technologies available on today’s market, to assess how they can contribute to the improvement and development of the services already available. Thus we ensure the continuous introduction of high quality equipment and components that offer high scientific and technical value. VIVISOL guarantees to provide effective healthcare solutions which are the result of innovation and scientific evolution, in order to assure public and private healthcare professionals that they have a reliable partner, who is always up-to-date with the latest developments in the international healthcare scene.